Download this Case Study
When Signifier Medical received FDA De Novo authorization in the U.S. for its clinically validated therapy for mild sleep apnea, eXciteOSA, the medical technology company’s leaders reached out to ZS to develop a product and commercial strategy. They looked to ZS for expertise in modeling health economics, payment models and storytelling for customers, including commercial payers and self-insured employers for both fee-for-service and value-based payment arrangements. Here’s how we achieved this.
Offered Free by: ZS Associates
See All Resources from: ZS Associates